COLUMBUS MCKINNON CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that COLUMBUS MCKINNON CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | $936.24M | May 25, 2023 |
| FY2023 | Mar 31, 2022 | $906.56M | May 25, 2023 |
| FY2023 | Mar 31, 2021 | $649.64M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $809.16M | May 25, 2022 |
| FY2021 | Mar 31, 2019 | $876.28M | May 26, 2021 |
| FY2020 | Mar 31, 2018 | $839.42M | May 27, 2020 |
| FY2019 | Mar 31, 2017 | $637.12M | May 29, 2019 |
| FY2018 | Mar 31, 2016 | $597.10M | May 30, 2018 |
| FY2017 | Mar 31, 2015 | $579.64M | May 31, 2017 |
| FY2016 | Mar 31, 2014 | $583.29M | Jun 1, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $963.03M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $1.01B | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $936.24M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $906.56M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $649.64M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $189.49M | May 27, 2020 |
| FY2020 | Dec 31, 2019 | $199.36M | May 27, 2020 |
| FY2020 | Sep 30, 2019 | $207.61M | May 27, 2020 |
| FY2020 | Jun 30, 2019 | $212.71M | May 27, 2020 |
| FY2020 | Mar 31, 2019 | $216.73M | May 27, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $214.14M | May 30, 2018 |
| FY2018 | Dec 31, 2017 | $208.73M | May 30, 2018 |
| FY2018 | Sep 30, 2017 | $212.83M | May 30, 2018 |
| FY2018 | Jun 30, 2017 | $203.73M | May 30, 2018 |
| FY2018 | Mar 31, 2017 | $183.69M | May 30, 2018 |
| FY2018 | Dec 31, 2016 | $152.50M | May 30, 2018 |
| FY2018 | Sep 30, 2016 | $151.93M | May 30, 2018 |
| FY2018 | Jun 30, 2016 | $149.01M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $155.09M | May 31, 2017 |
| FY2017 | Dec 31, 2015 | $159.74M | May 31, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $325.68M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $374.84M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $342.10M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $315.73M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $220.23M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $66.21M | May 27, 2020 |
| FY2020 | Dec 31, 2019 | $67.87M | May 27, 2020 |
| FY2020 | Sep 30, 2019 | $73.49M | May 27, 2020 |
| FY2020 | Jun 30, 2019 | $75.61M | May 27, 2020 |
| FY2020 | Mar 31, 2019 | $76.05M | May 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($5.14M) | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $46.63M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $48.43M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $29.66M | May 29, 2024 |
| FY2020 | Mar 31, 2020 | $9.24M | May 27, 2020 |
| FY2020 | Dec 31, 2019 | $15.25M | May 27, 2020 |
| FY2020 | Sep 30, 2019 | $16.60M | May 27, 2020 |
| FY2020 | Jun 30, 2019 | $18.58M | May 27, 2020 |
| FY2020 | Mar 31, 2019 | $19.74M | May 27, 2020 |
| FY2020 | Dec 31, 2018 | ($782.0K) | May 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $54.57M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $107.15M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $97.84M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $73.78M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $42.26M | May 25, 2023 |
| FY2020 | Mar 31, 2020 | $16.66M | May 27, 2020 |
| FY2020 | Dec 31, 2019 | $20.89M | May 27, 2020 |
| FY2020 | Sep 30, 2019 | $25.23M | May 27, 2020 |
| FY2020 | Jun 30, 2019 | $27.04M | May 27, 2020 |
| FY2020 | Mar 31, 2019 | $24.47M | May 27, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $23.87M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $26.19M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $20.94M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $15.35M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $12.41M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $11.31M | May 25, 2022 |
| FY2021 | Mar 31, 2019 | $13.49M | May 26, 2021 |
| FY2020 | Mar 31, 2018 | $13.62M | May 27, 2020 |
| FY2019 | Mar 31, 2017 | $10.48M | May 29, 2019 |
| FY2018 | Mar 31, 2016 | $7.39M | May 30, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $45.61M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $67.20M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $83.64M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $48.88M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $98.89M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $106.80M | May 25, 2022 |
| FY2021 | Mar 31, 2019 | $79.50M | May 26, 2021 |
| FY2020 | Mar 31, 2018 | $69.66M | May 27, 2020 |
| FY2019 | Mar 31, 2017 | $60.45M | May 29, 2019 |
| FY2018 | Mar 31, 2016 | $52.65M | May 30, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $21.41M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $24.81M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $12.63M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $13.10M | May 29, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.74B | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $1.83B | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $1.70B | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $1.69B | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $1.15B | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $1.09B | May 25, 2022 |
| FY2021 | Mar 31, 2019 | $1.06B | May 26, 2021 |
| FY2020 | Mar 31, 2018 | $1.14B | May 27, 2020 |
| FY2019 | Mar 31, 2017 | $1.11B | May 29, 2019 |
| FY2018 | Mar 31, 2016 | $772.85M | May 30, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $856.69M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $943.88M | May 28, 2025 |
| FY2024 | Mar 31, 2023 | $864.66M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $912.90M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $620.28M | May 25, 2022 |
| FY2021 | Mar 31, 2020 | $629.69M | May 26, 2021 |
| FY2020 | Mar 31, 2019 | $630.41M | May 27, 2020 |
| FY2019 | Mar 31, 2018 | $734.22M | May 29, 2019 |
| FY2018 | Mar 31, 2017 | $772.49M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $486.54M | May 31, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $882.10M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $882.06M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $833.80M | May 28, 2025 |
| FY2025 | Mar 31, 2022 | $772.80M | May 28, 2025 |
| FY2024 | Mar 31, 2021 | $530.15M | May 29, 2024 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $710.81M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $710.33M | May 28, 2025 |
| FY2025 | Mar 31, 2023 | $644.63M | May 28, 2025 |
| FY2024 | Mar 31, 2022 | $648.85M | May 29, 2024 |
| FY2023 | Mar 31, 2021 | $331.18M | May 25, 2023 |
| FY2022 | Mar 31, 2020 | $319.68M | May 25, 2022 |
| FY2021 | Mar 31, 2019 | $322.82M | May 26, 2021 |
| FY2020 | Mar 31, 2018 | $347.43M | May 27, 2020 |
| FY2019 | Mar 31, 2017 | $319.30M | May 29, 2019 |
| FY2017 | Mar 31, 2016 | $170.72M | May 31, 2017 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $382.16M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $395.33M | May 28, 2025 |
| FY2024 | Mar 31, 2023 | $356.76M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $316.34M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $293.80M | May 25, 2022 |
| FY2021 | Mar 31, 2020 | $290.44M | May 26, 2021 |
| FY2020 | Mar 31, 2019 | $236.46M | May 27, 2020 |
| FY2019 | Mar 31, 2018 | $197.90M | May 29, 2019 |
| FY2018 | Mar 31, 2017 | $179.74M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $174.17M | May 31, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $53.68M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $114.13M | May 28, 2025 |
| FY2024 | Mar 31, 2023 | $133.18M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $115.39M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $202.13M | May 25, 2022 |
| FY2021 | Mar 31, 2020 | $114.45M | May 26, 2021 |
| FY2020 | Mar 31, 2019 | $71.09M | May 27, 2020 |
| FY2019 | Mar 31, 2018 | $63.02M | May 29, 2019 |
| FY2019 | Mar 31, 2017 | $77.59M | May 29, 2019 |
| FY2018 | Mar 31, 2016 | $51.60M | May 30, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $458.71M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | $517.30M | May 28, 2025 |
| FY2024 | Mar 31, 2023 | $458.05M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | $497.14M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | $248.95M | May 25, 2022 |
| FY2021 | Mar 31, 2020 | $251.31M | May 26, 2021 |
| FY2020 | Mar 31, 2019 | $300.32M | May 27, 2020 |
| FY2019 | Mar 31, 2018 | $363.32M | May 29, 2019 |
| FY2018 | Mar 31, 2017 | $421.32M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | $267.63M | May 31, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | May 28, 2025 |
| FY2025 | Mar 31, 2024 | 1 | May 28, 2025 |
| FY2025 | Mar 31, 2023 | 1 | May 28, 2025 |
| FY2024 | Mar 31, 2022 | 1 | May 29, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 27, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 27, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 27, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 27, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 27, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | May 28, 2025 |
| FY2025 | Mar 31, 2024 | 1 | May 28, 2025 |
| FY2025 | Mar 31, 2023 | 1 | May 28, 2025 |
| FY2024 | Mar 31, 2022 | 1 | May 29, 2024 |
| FY2023 | Mar 31, 2021 | 0 | May 25, 2023 |
| FY2020 | Mar 31, 2020 | 0 | May 27, 2020 |
| FY2020 | Dec 31, 2019 | 0 | May 27, 2020 |
| FY2020 | Sep 30, 2019 | 0 | May 27, 2020 |
| FY2020 | Jun 30, 2019 | 0 | May 27, 2020 |
| FY2020 | Mar 31, 2019 | 0 | May 27, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 28.62M | May 28, 2025 |
| FY2025 | Mar 31, 2024 | 28.80M | May 28, 2025 |
| FY2024 | Mar 31, 2023 | 28.61M | May 29, 2024 |
| FY2023 | Mar 31, 2022 | 28.52M | May 25, 2023 |
| FY2022 | Mar 31, 2021 | 23.98M | May 25, 2022 |
| FY2021 | Mar 31, 2020 | 23.77M | May 26, 2021 |
| FY2020 | Mar 31, 2019 | 23.39M | May 27, 2020 |
| FY2019 | Mar 31, 2018 | 23.05M | May 29, 2019 |
| FY2018 | Mar 31, 2017 | 22.57M | May 30, 2018 |
| FY2017 | Mar 31, 2016 | 20.11M | May 31, 2017 |